Aurora Innovation, Inc. — Form 10-Q
Filed October 28, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Aurora Innovation amended and restated its Controlled Equity Offering sales agreement dated February 14, 2025, effective October 28, 2026. The agreement authorizes sale of up to $1 billion in Class A common stock through six agents (Cantor Fitzgerald, Allen & Company, TD Securities, Canaccord Genuity, Oppenheimer, Craig-Hallum). Agents receive up to 3.0% commission on sales. The amendment adds Canaccord Genuity, Oppenheimer, and Craig-Hallum as new agents and restates terms; specific dollar amounts previously sold are not disclosed in this filing.
Why this rating
ATM offering agreement amendment is routine capital-raising infrastructure. $1B authorization is ~18% of $5.7B market cap but is prospective capacity, not actual capital raised. Specific sales proceeds not disclosed here.
Extracted items
- 8.01 other event
- 2.01 acquisition/disposition
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.